Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK)
HKD 11.12
(0.18%)
HKD 11.12
(0.18%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -1.03 Billion CNY | 13.48% |
| 2022 | -1.19 Billion CNY | 15.45% |
| 2021 | -1.4 Billion CNY | -5461.29% |
| 2020 | -25.33 Million CNY | -11.21% |
| 2019 | -22.78 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -457.6 Million CNY | 55.6% |
| 2024 Q2 | -457.6 Million CNY | 1.36% |
| 2023 Q2 | -1.28 Billion CNY | 0.43% |
| 2023 FY | -1.03 Billion CNY | 13.48% |
| 2023 Q4 | -1.03 Billion CNY | 0.39% |
| 2023 Q3 | -1.03 Billion CNY | 19.62% |
| 2023 Q1 | -1.29 Billion CNY | -8.53% |
| 2022 Q2 | -1.04 Billion CNY | 0.45% |
| 2022 Q1 | -1.05 Billion CNY | 25.44% |
| 2022 FY | -1.19 Billion CNY | 15.45% |
| 2022 Q4 | -1.19 Billion CNY | 0.55% |
| 2022 Q3 | -1.19 Billion CNY | -14.54% |
| 2021 Q2 | -38.45 Million CNY | 6.4% |
| 2021 Q4 | -1.4 Billion CNY | 0.21% |
| 2021 Q3 | -1.41 Billion CNY | -3571.43% |
| 2021 Q1 | -41.08 Million CNY | -62.16% |
| 2021 FY | -1.4 Billion CNY | -5461.29% |
| 2020 FY | -25.33 Million CNY | -11.21% |
| 2020 Q4 | -25.33 Million CNY | 10.03% |
| 2020 Q3 | -28.16 Million CNY | 0.0% |
| 2020 Q1 | 101.51 Million CNY | 0.0% |
| 2019 FY | -22.78 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Vincent Medical Holdings Limited | -138.39 Million HKD | -644.732% |